AI技术在研发中的应用
Search documents
药康生物2025年业绩快报发布,营收净利双增长
Jing Ji Guan Cha Wang· 2026-02-14 03:16
Group 1 - The company reported a 15.49% year-on-year increase in operating revenue, reaching 793 million yuan for the year 2025 [1][2] - The net profit attributable to the parent company grew by 31.49% year-on-year, amounting to 144 million yuan [1][2] - A detailed annual report for 2025 is expected to be released soon, providing more comprehensive financial and operational data [1][2] Group 2 - The company's share repurchase plan, which commenced on October 31, 2024, may be nearing completion, although there have been no recent updates [3] - The company is recognized as a national-level "little giant" enterprise specializing in innovation, continuously exploring the application of AI technology in research and development [3]